Offene Stellen
Showing 780 results
- Sort by Sort ascending
- Stellenbezeichnung Sort ascending
- Business
- Land
- Ort
- Datum der Veröffentlichung
| Stellenbezeichnung Sort ascending | Business | Land | Ort | Datum der Veröffentlichung |
|---|---|---|---|---|
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Southern California Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | 02. Dezember 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Mid-West Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | 02. Dezember 2025 |
| Operational Excellence (OpEx) Manager (m/f/d), temporary Temporary (Fixed Term), Full time | Production / Manufacturing | Österreich | Kundl | 02. Dezember 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Gulf Coast Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | 02. Dezember 2025 |
| Tehnik vzdrževanja tehničnih storitev II (m/ž/d), Ljubljana Regular, Full time | Production / Manufacturing | Slowenien | Ljubljana | 02. Dezember 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - New England Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | 02. Dezember 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Wisconsin Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | 02. Dezember 2025 |
| Senior QA Expert ESO Temporary (Fixed Term), Full time | Quality | Polen +Alternative Locations | Warsaw | 02. Dezember 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Chicago Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | 02. Dezember 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Tri- State Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | 02. Dezember 2025 |